¿Qué es la enfermedad de Alzheimer?




descargar 0.56 Mb.
título¿Qué es la enfermedad de Alzheimer?
página8/9
fecha de publicación27.03.2017
tamaño0.56 Mb.
tipoDocumentos
med.se-todo.com > Documentos > Documentos
1   2   3   4   5   6   7   8   9
[PubMed - indexed for MEDLINE]


3: Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, Buxbaum JD,Mohs RC, Aisen PS, Pasinetti GM.
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function
of the clinical progression of Alzheimer disease.
Arch Neurol. 2001 Mar;58(3):487-92.
PMID: 11255454 [PubMed - indexed for MEDLINE]


4: Hoozemans JJ, Veerhuis R, Janssen I, Rozemuller AJ, Eikelenboom P.Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2
secretion by human neuroblastoma cells: implications for Alzheimer's disease.
Exp Gerontol. 2001 Mar;36(3):559-70.
PMID: 11250126 [PubMed - indexed for MEDLINE]


5: Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR.Protein oxidation in the brain in Alzheimer's disease.
Neuroscience. 2001;103(2):373-83.
PMID: 11246152 [PubMed - indexed for MEDLINE]


  1. 6: Hoozemans JJ, Rozemuller AJ, Janssen I, De Groot CJ, Veerhuis R, Eikelenboom

  2. P.
    Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and
    control brain.
    Acta Neuropathol (Berl). 2001 Jan;101(1):2-8.
    PMID: 11194936 [PubMed - indexed for MEDLINE]




7: Atwood CS, Huang X, Khatri A, Scarpa RC, Kim YS, Moir RD, Tanzi RE, Roher AE,Bush AI.
Copper catalyzed oxidation of Alzheimer Abeta.
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):777-83.
PMID: 10875439 [PubMed - indexed for MEDLINE]


8: Blain H, Jouzeau JY, Blain A, Terlain B, Trechot P, Touchon J, Netter P,Jeandel C.
[Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in
Alzheimer's disease. Rationale and perspectives]
Presse Med. 2000 Feb 12;29(5):267-73. Review. French.
PMID: 10701410 [PubMed - indexed for MEDLINE]

9: Schippling S, Kontush A, Arlt S, Buhmann C, Sturenburg HJ, Mann U,Muller-Thomsen T, Beisiegel U.
Increased lipoprotein oxidation in Alzheimer's disease.
Free Radic Biol Med. 2000 Feb 1;28(3):351-60.
PMID: 10699746 [PubMed - indexed for MEDLINE]

1: Tschampa HJ, Neumann M, Zerr I, Henkel K, Schroter A, Schulz-Schaeffer WJ,Steinhoff BJ, Kretzschmar HA, Poser S.
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for
Creutzfeldt-Jakob disease.
J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):33-9.
PMID: 11413259 [PubMed - indexed for MEDLINE]


2: Weller RO.How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob
and Alzheimer's diseases?
J Pathol. 2001 May;194(1):1-3.
PMID: 11329133 [PubMed - indexed for MEDLINE]


3: Cheon MS, Bajo M, Gulesserian T, Cairns N, Lubec G.Evidence for the relation of herpes simplex virus type 1 to Down syndrome and
Alzheimer's disease.
Electrophoresis. 2001 Feb;22(3):445-8.
PMID: 11258753 [PubMed - indexed for MEDLINE]


4: Armstrong RA, Lantos PL, Cairns NJ.The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease:
comparison with beta-amyloid deposits in Alzheimer's disease.
Neurosci Lett. 2001 Jan 26;298(1):53-6.
PMID: 11154834 [PubMed - indexed for MEDLINE]


5: Cribbs DH, Azizeh BY, Cotman CW, LaFerla FM.Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B
fragment with homology to the Alzheimer's A beta peptide.
Biochemistry. 2000 May 23;39(20):5988-94.
PMID: 10821670 [PubMed - indexed for MEDLINE]

1: Solomon B, Koppel R, Jossiphov J.Immunostaining of calmodulin and aluminium in Alzheimer's disease-affected
brains.
Brain Res Bull. 2001 May 15;55(2):253-6.
PMID: 11470324 [PubMed - indexed for MEDLINE]


2: Flaten TP.Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking
water.
Brain Res Bull. 2001 May 15;55(2):187-96. Review.
PMID: 11470314 [PubMed - indexed for MEDLINE]


3: Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G.Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson
diseases.
Brain Res Bull. 2001 May 15;55(2):175-85. Review.
PMID: 11470313 [PubMed - indexed for MEDLINE]


4: Kozin SA, Zirah S, Rebuffat S, Hoa GH, Debey P.Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble
complex.
Biochem Biophys Res Commun. 2001 Jul 27;285(4):959-64.
PMID: 11467845 [PubMed - indexed for MEDLINE]


5: Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, Beyreuther K, BarrowCJ, Masters CL, Bush AI, Barnham KJ.
Alzheimer's disease amyloid-beta binds copper and zinc to generate an
allosterically ordered membrane-penetrating structure containing superoxide
dismutase-like subunits.
J Biol Chem. 2001 Jun 8;276(23):20466-73.
PMID: 11274207 [PubMed - indexed for MEDLINE]


6: Yu WH, Fraser PE.S100beta interaction with tau is promoted by zinc and inhibited by
hyperphosphorylation in Alzheimer's disease.
J Neurosci. 2001 Apr 1;21(7):2240-6.
PMID: 11264299 [PubMed - indexed for MEDLINE]


7: White AR, Huang X, Jobling MF, Barrow CJ, Beyreuther K, Masters CL, Bush AI,Cappai R.
Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in
primary neuronal cultures: possible risk factors in the Alzheimer's-type
neurodegenerative pathways.
J Neurochem. 2001 Mar;76(5):1509-20.
PMID: 11238735 [PubMed - indexed for MEDLINE]


8: Rulon LL, Robertson JD, Lovell MA, Deibel MA, Ehmann WD, Markesber WR.Serum zinc levels and Alzheimer's disease.
Biol Trace Elem Res. 2000 Summer;75(1-3):79-85.
PMID: 11051598 [PubMed - indexed for MEDLINE]

9: Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, BushAI.
Characterization of copper interactions with alzheimer amyloid beta peptides:
identification of an attomolar-affinity copper binding site on amyloid beta1-42.
J Neurochem. 2000 Sep;75(3):1219-33.
PMID: 10936205 [PubMed - indexed for MEDLINE]


10: Bartzokis G, Tishler TA.MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's
and Huntingon's disease.
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33.
PMID: 10875443 [PubMed - indexed for MEDLINE]


11: Atwood CS, Huang X, Khatri A, Scarpa RC, Kim YS, Moir RD, Tanzi RE, RoherAE, Bush AI.
Copper catalyzed oxidation of Alzheimer Abeta.
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):777-83.
PMID: 10875439 [PubMed - indexed for MEDLINE]


12: Pinero DJ, Hu J, Connor JR.Alterations in the interaction between iron regulatory proteins and their iron
responsive element in normal and Alzheimer's diseased brains.
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):761-76.
PMID: 10875438 [PubMed - indexed for MEDLINE]


13: Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI.Alzheimer's disease, beta-amyloid protein and zinc.
J Nutr. 2000 May;130(5S Suppl):1488S-92S. Review.
PMID: 10801964 [PubMed - indexed for MEDLINE]


14: Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, HuangX, Farrag YW, Perry G, Bush AI.
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the
redox-silencing and entombment of abeta by zinc.
J Biol Chem. 2000 Jun 30;275(26):19439-42.
PMID: 10801774 [PubMed - indexed for MEDLINE]


15: Suh SW, Jensen KB, Jensen MS, Silva DS, Kesslak PJ, Danscher G, FredericksonCJ.
Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating
neurons of Alzheimer's diseased brains.
Brain Res. 2000 Jan 10;852(2):274-8.
PMID: 10678753 [PubMed - indexed for MEDLINE]


16: Moore PB, Day JP, Taylor GA, Ferrier IN, Fifield LK, Edwardson JA.Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator
mass spectrometry.
Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):66-9.
PMID: 10705162 [PubMed - indexed for MEDLINE]



  1. 17: Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, Mintz

  2. J.
    In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance
    imaging.
    Arch Gen Psychiatry. 2000 Jan;57(1):47-53.
    PMID: 10632232 [PubMed - indexed for MEDLINE]




1: Graves AB, Rosner D, Echeverria D, Yost M, Larson EB.Occupational exposure to electromagnetic fields and Alzheimer disease.
Alzheimer Dis Assoc Disord. 1999 Jul-Sep;13(3):165-70.
PMID: 10485576 [PubMed - indexed for MEDLINE]


2: Sobel E, Davanipour Z.Electromagnetic field exposure may cause increased production of amyloid beta
and eventually lead to Alzheimer's disease.
Neurology. 1996 Dec;47(6):1594-600. No abstract available.
PMID: 8960756 [PubMed - indexed for MEDLINE]


3: Sobel E, Dunn M, Davanipour Z, Qian Z, Chui HC.Elevated risk of Alzheimer's disease among workers with likely electromagnetic
field exposure.
Neurology. 1996 Dec;47(6):1477-81.
PMID: 8960730 [PubMed - indexed for MEDLINE]

1: Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D,Phillips C, Gau BA, Welsh-Bohmer KA, Burke JR, Guralnik JM, Breitner JC.
Documented head injury in early adulthood and risk of Alzheimer's disease and
other dementias.
Neurology. 2000 Oct 24;55(8):1158-66.
PMID: 11071494 [PubMed - indexed for MEDLINE]


2: O'Meara ES, Kukull WA, Sheppard L, Bowen JD, McCormick WC, Teri L,Pfanschmidt M, Thompson JD, Schellenberg GD, Larson EB.
Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
Am J Epidemiol. 1997 Sep 1;146(5):373-84.
PMID: 9290497 [PubMed - indexed for MEDLINE]


3: Salib E, Hillier V.Head injury and the risk of Alzheimer's disease: a case control study.
Int J Geriatr Psychiatry. 1997 Mar;12(3):363-8.
PMID: 9152722 [PubMed - indexed for MEDLINE]


4: Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Chun M, Sano M, Stern Y,Mayeux R.
Alzheimer's disease after remote head injury: an incidence study.
J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):119-24.
PMID: 9048710 [PubMed - indexed for MEDLINE]


5: Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P,Stern Y, Tycko B, Mayeux R.
Effect of age, ethnicity, and head injury on the association between APOE
genotypes and Alzheimer's disease.
Ann N Y Acad Sci. 1996 Dec 16;802:6-15.
PMID: 8993479 [PubMed - indexed for MEDLINE]


6: Graham DI, Gentleman SM, Nicoll JA, Royston MC, McKenzie JE, Roberts GW,Griffin WS.
Altered beta-APP metabolism after head injury and its relationship to the
aetiology of Alzheimer's disease.
Acta Neurochir Suppl (Wien). 1996;66:96-102. Review.
PMID: 8780805 [PubMed - indexed for MEDLINE]



  1. 1: Mortimer JA.Brain reserve and the clinical expression of Alzheimer's disease.
    Geriatrics. 1997 Sep;52 Suppl 2:S50-3.
    PMID: 9307589 [PubMed - indexed for MEDLINE]



  2. 1: Ito T, Yamadera H, Ito R, Suzuki H, Asayama K, Endo S.Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in
    Alzheimer-type dementia.
    Psychiatry Clin Neurosci. 2001 Jun;55(3):281-2.
    PMID: 11422876 [PubMed - indexed for MEDLINE]




2: Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L.Vitamin B(12) and folate in relation to the development of Alzheimer's disease.
Neurology. 2001 May 8;56(9):1188-94.
PMID: 11342684 [PubMed - indexed for MEDLINE]


3: McCaddon A, Hudson P, Abrahamsson L, Olofsson H, Regland B.Analogues, ageing and aberrant assimilation of vitamin B12 in Alzheimer's
disease.
Dement Geriatr Cogn Disord. 2001 Mar-Apr;12(2):133-7.
PMID: 11173886 [PubMed - indexed for MEDLINE]


4: Meins W, Muller-Thomsen T, Meier-Baumgartner HP.Subnormal serum vitamin B12 and behavioural and psychological symptoms in
Alzheimer's disease.
Int J Geriatr Psychiatry. 2000 May;15(5):415-8.
PMID: 10822240 [PubMed - indexed for MEDLINE]


5: McCaddon A, Davies G, Hudson P.Nutritionally independent B12 deficiency and Alzheimer disease.
Arch Neurol. 2000 Apr;57(4):607-8. No abstract available.
PMID: 10768642 [PubMed - indexed for MEDLINE]


6: Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR.Serum folate and the severity of atrophy of the neocortex in Alzheimer disease:
findings from the Nun study.
Am J Clin Nutr. 2000 Apr;71(4):993-8.
PMID: 10731508 [PubMed - indexed for MEDLINE]

1: Polo-Kantola P, Erkkola R.Alzheimer's disease and estrogen replacement therapy--where are we now?
Acta Obstet Gynecol Scand. 2001 Aug;80(8):679-82. No abstract available.
PMID: 11531607 [PubMed - indexed for MEDLINE]


2: Savaskan E, Olivieri G, Meier F, Ravid R, Muller-Spahn F.Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's
disease.
Brain Res. 2001 Jul 27;908(2):113-9.
PMID: 11454321 [PubMed - indexed for MEDLINE]


3: Thomas T.A role for estrogen in the primary prevention of Alzheimer's disease.
Climacteric. 2001 Jun;4(2):102-9. Review. No abstract available.
PMID: 11428174 [PubMed - indexed for MEDLINE]


4: Lambert JC, Harris JM, Mann D, Lemmon H, Coates J, Cumming A, St-Clair D,Lendon C.
Are the estrogen receptors involved in Alzheimer's disease?
Neurosci Lett. 2001 Jun 29;306(3):193-7.
PMID: 11406328 [PubMed - indexed for MEDLINE]


5: Brinton RD.Cellular and molecular mechanisms of estrogen regulation of memory function and
neuroprotection against Alzheimer's disease: recent insights and remaining
challenges.
Learn Mem. 2001 May-Jun;8(3):121-33. Review.
PMID: 11390632 [PubMed - indexed for MEDLINE]


6: Honjo H, Kikuchi N, Hosoda T, Kariya K, Kinoshita Y, Iwasa K, Ohkubo T,Tanaka K, Tamura T, Urabe M, Kawata M.
Alzheimer's disease and estrogen.
J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):227-30. Review.
PMID: 11384881 [PubMed - indexed for MEDLINE]


7: Ishunina TA, Swaab DF.Increased expression of estrogen receptor alpha and beta in the nucleus basalis
of Meynert in Alzheimer's disease.
Neurobiol Aging. 2001 May-Jun;22(3):417-26.
PMID: 11378248 [PubMed - indexed for MEDLINE]


8: Panidis DK, Matalliotakis IM, Rousso DH, Kourtis AI, Koumantakis EE.The role of estrogen replacement therapy in Alzheimer's disease.
Eur J Obstet Gynecol Reprod Biol. 2001 Mar;95(1):86-91. Review.
PMID: 11267726 [PubMed - indexed for MEDLINE]


9: Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA.Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.
Arch Neurol. 2001 Mar;58(3):435-40.

PMID: 11255447 [PubMed - indexed for MEDLINE]

10: Aviel-Ronen S, Shalmon B, Nass D.[Alzheimer disease and estrogen--the connection, modes of influence and the
therapy]
Harefuah. 2001 Feb;140(2):139-43. Review. Hebrew. No abstract available.
PMID: 11242920 [PubMed - indexed for MEDLINE]


11: Green PS, Simpkins JW.Estrogens and estrogen-like non-feminizing compounds. Their role in the
prevention and treatment of Alzheimer's disease.
Ann N Y Acad Sci. 2000;924:93-8. Review.
PMID: 11193809 [PubMed - indexed for MEDLINE]


12: [No authors listed]Estrogen not effective for Alzheimer's disease.
Harv Ment Health Lett. 2000 Oct;17(4):6. No abstract available.
PMID: 11015757 [PubMed - indexed for MEDLINE]


13: Greene RA.Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen
on the incidence and treatment of Alzheimer's disease.
Int J Fertil Womens Med. 2000 Jul-Aug;45(4):253-7.
PMID: 10997480 [PubMed - indexed for MEDLINE]


14: Gandy S, Duff K.Post-menopausal estrogen deprivation and Alzheimer's disease.
Exp Gerontol. 2000 Jul;35(4):503-11. Review.
PMID: 10959038 [PubMed - indexed for MEDLINE]


15: Toran-Allerand CD.Estrogen as a treatment for Alzheimer disease.
JAMA. 2000 Jul 19;284(3):307-8. No abstract available.
PMID: 10891957 [PubMed - indexed for MEDLINE]


16: Cosgrove D.Estrogen as a treatment for Alzheimer disease.
JAMA. 2000 Jul 19;284(3):307; discussion 308. No abstract available.
PMID: 10891956 [PubMed - indexed for MEDLINE]


17: Marder K, Sano M.Estrogen to treat Alzheimer's disease: too little, too late? So what's a woman
to do?
Neurology. 2000 Jun 13;54(11):2035-7. No abstract available.
PMID: 10851358 [PubMed - indexed for MEDLINE]


18: Flam F.[New reports on estrogen therapy. Increased risk of breast cancer; no effects on
Alzheimer disease]

Lakartidningen. 2000 May 3;97(18):2166-9. Swedish. No abstract available. PMID: 10850046 [PubMed - indexed for MEDLINE]

19: Thomas T, Rhodin J.Vascular actions of estrogen and Alzheimer's disease.
Ann N Y Acad Sci. 2000 Apr;903:501-9.
PMID: 10818545 [PubMed - indexed for MEDLINE]


20: Ji Y, Urakami K, Wada-Isoe K, Adachi Y, Nakashima K.Estrogen receptor gene polymorphisms in patients with Alzheimer's disease,
vascular dementia and alcohol-associated dementia.
Dement Geriatr Cogn Disord. 2000 May-Jun;11(3):119-22.
PMID: 10765041 [PubMed - indexed for MEDLINE]


21: Mattila KM, Axelman K, Rinne JO, Blomberg M, Lehtimaki T, Laippala P, RoyttaM, Viitanen M, Wahlund L, Winblad B, Lannfelt L.
Interaction between estrogen receptor 1 and the epsilon4 allele of
apolipoprotein E increases the risk of familial Alzheimer's disease in women.
Neurosci Lett. 2000 Mar 17;282(1-2):45-8.
PMID: 10713392 [PubMed - indexed for MEDLINE]


22: Shaywitz BA, Shaywitz SE.Estrogen and Alzheimer disease: plausible theory, negative clinical trial.
JAMA. 2000 Feb 23;283(8):1055-6. No abstract available.
PMID: 10697067 [PubMed - indexed for MEDLINE]


23: Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E,Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ.
Estrogen replacement therapy for treatment of mild to moderate Alzheimer
disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
JAMA. 2000 Feb 23;283(8):1007-15.
PMID: 10697060 [PubMed - indexed for MEDLINE]


24: Manly JJ, Merchant CA, Jacobs DM, Small SA, Bell K, Ferin M, Mayeux R.Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.
Neurology. 2000 Feb 22;54(4):833-7.
PMID: 10690972 [PubMed - indexed for MEDLINE]


25: Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T, Arai H,Yasuda M, Tanaka C, Emson PC, Nakamura S, Kawakami H.
Lack of an association of estrogen receptor alpha gene polymorphisms and
transcriptional activity with Alzheimer disease.
Arch Neurol. 2000 Feb;57(2):236-40.
PMID: 10681083 [PubMed - indexed for MEDLINE]


26: Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D,McCleary CA, Klein RA, Hake AM, Farlow MR.
Estrogen for Alzheimer's disease in women: randomized, double-blind,
placebo-controlled trial.
Neurology. 2000 Jan 25;54(2):295-301.

PMID: 10668686 [PubMed - indexed for MEDLINE]

1: Ferencik M, Novak M, Rovensky J, Rybar I.Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs.
Bratisl Lek Listy. 2001;102(3):123-32. Review.
PMID: 11433600 [PubMed - indexed for MEDLINE]


2: Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, Buxbaum JD,Mohs RC, Aisen PS, Pasinetti GM.
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function
of the clinical progression of Alzheimer disease.
Arch Neurol. 2001 Mar;58(3):487-92.
PMID: 11255454 [PubMed - indexed for MEDLINE]


3: Hoozemans JJ, Veerhuis R, Janssen I, Rozemuller AJ, Eikelenboom P.Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2
secretion by human neuroblastoma cells: implications for Alzheimer's disease.
Exp Gerontol. 2001 Mar;36(3):559-70.
PMID: 11250126 [PubMed - indexed for MEDLINE]


  1. 4: Hoozemans JJ, Rozemuller AJ, Janssen I, De Groot CJ, Veerhuis R, Eikelenboom

  2. P.
    Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and
    control brain.
    Acta Neuropathol (Berl). 2001 Jan;101(1):2-8.
    PMID: 11194936 [PubMed - indexed for MEDLINE]




5: Blain H, Jouzeau JY, Blain A, Terlain B, Trechot P, Touchon J, Netter P,Jeandel C.
[Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in
Alzheimer's disease. Rationale and perspectives]
Presse Med. 2000 Feb 12;29(5):267-73. Review. French.
PMID: 10701410 [PubMed - indexed for MEDLINE]


6: Yermakova AV, Rollins J, Callahan LM, Rogers J, O'Banion MK.Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of
expression by microglia and CA3 hippocampal neurons.
J Neuropathol Exp Neurol. 1999 Nov;58(11):1135-46.
PMID: 10560656 [PubMed - indexed for MEDLINE]


7: Ho L, Pieroni C, Winger D, Purohit DP, Aisen PS, Pasinetti GM.Regional distribution of cyclooxygenase-2 in the hippocampal formation in
Alzheimer's disease.
J Neurosci Res. 1999 Aug 1;57(3):295-303.
PMID: 10412020 [PubMed - indexed for MEDLINE]


8: in 't Veld BA, Launer LJ, Hoes AW, Ott A, Hofman A, Breteler MM, Stricker BH.NSAIDs and incident Alzheimer's disease. The Rotterdam Study.
Neurobiol Aging. 1998 Nov-Dec;19(6):607-11.
PMID: 10192221 [PubMed - indexed for MEDLINE]

9: Pasinetti GM.Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches
and clinical interventions.
J Neurosci Res. 1998 Oct 1;54(1):1-6. Review.
PMID: 9778144 [PubMed - indexed for MEDLINE]


10: Pasinetti GM, Aisen PS.Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's
disease brain.
Neuroscience. 1998 Nov;87(2):319-24.
PMID: 9740394 [PubMed - indexed for MEDLINE]


11: Lukiw WJ, Bazan NG.Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene
transcription in aging and in sporadic Alzheimer's disease superior temporal
lobe neocortex.
J Neurosci Res. 1998 Sep 1;53(5):583-92.
PMID: 9726429 [PubMed - indexed for MEDLINE]

1: Simons M, Keller P, Dichgans J, Schulz JB.Cholesterol and Alzheimer's disease: is there a link?
Neurology. 2001 Sep 25;57(6):1089-93.
PMID: 11571339 [PubMed - indexed for MEDLINE]


2: Friedhoff LT, Cullen EI, Geoghagen NS, Buxbaum JD.Treatment with controlled-release lovastatin decreases serum concentrations of
human beta-amyloid (A beta) peptide.
Int J Neuropsychopharmacol. 2001 Jun;4(2):127-30.
PMID: 11466161 [PubMed - indexed for MEDLINE]


3: Cucchiara B, Kasner SE.Use of statins in CNS disorders.
J Neurol Sci. 2001 Jun 15;187(1-2):81-9. Review.
PMID: 11440749 [PubMed - indexed for MEDLINE]


4: Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F.Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the
alpha -secretase ADAM 10.
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5815-20.
PMID: 11309494 [PubMed - indexed for MEDLINE]


5: Emre M, Qizilbash N.Experimental approaches and drugs in development for the treatment of dementia.
Expert Opin Investig Drugs. 2001 Apr;10(4):607-17. Review.
PMID: 11281812 [PubMed - indexed for MEDLINE]


  1. 6: Siest G, Bertrand P, Herbeth B, Vincent-Viry M, Schiele F, Sass C, Visvikis

  2. S.
    Apolipoprotein E polymorphisms and concentration in chronic diseases and drug
    responses.
    Clin Chem Lab Med. 2000 Sep;38(9):841-52. Review.
    PMID: 11097338 [PubMed - indexed for MEDLINE]




7: Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA.Statins and the risk of dementia.
Lancet. 2000 Nov 11;356(9242):1627-31.
PMID: 11089820 [PubMed - indexed for MEDLINE]


8: Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G.Decreased prevalence of Alzheimer disease associated with
3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
Arch Neurol. 2000 Oct;57(10):1439-43.
PMID: 11030795 [PubMed - indexed for MEDLINE]

1: Horrocks LA, Yeo YK.Health benefits of docosahexaenoic acid (DHA)
Pharmacol Res. 1999 Sep;40(3):211-25. Review.
PMID: 10479465 [PubMed - indexed for MEDLINE]


2: Khalsa DS.Integrated medicine and the prevention and reversal of memory loss.
Altern Ther Health Med. 1998 Nov;4(6):38-43. Review.
PMID: 9810066 [PubMed - indexed for MEDLINE]


3: Spindler AA, Renvall MJ, Nichols JF, Ramsdell JW.Nutritional status of patients with Alzheimer's disease: a 1-year study.
J Am Diet Assoc. 1996 Oct;96(10):1013-8.
PMID: 8841163 [PubMed - indexed for MEDLINE]

1: Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM.Nutritional factors in cerebral aging and dementia: epidemiological arguments
for a role of oxidative stress.
Neuroepidemiology. 2001 Feb;20(1):7-15. Review.
PMID: 11174040 [PubMed - indexed for MEDLINE]


2: Villeponteau B, Cockrell R, Feng J.Nutraceutical interventions may delay aging and the age-related diseases.
Exp Gerontol. 2000 Dec;35(9-10):1405-17.
PMID: 11113618 [PubMed - indexed for MEDLINE]


3: Ross GW, Petrovitch H, White LR, Masaki KH, Li CY, Curb JD, Yano K, RodriguezBL, Foley DJ, Blanchette PL, Havlik R.
Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging
Study.
Neurology. 1999 Jul 22;53(2):337-43.
PMID: 10430423 [PubMed - indexed for MEDLINE]


4: Shaw CA, Bains JS.Did consumption of flour bleached by the agene process contribute to the
incidence of neurological disease?
Med Hypotheses. 1998 Dec;51(6):477-81. Review.
PMID: 10052866 [PubMed - indexed for MEDLINE]


5: Riviere S, Birlouez-Aragon I, Nourhashemi F, Vellas B.Low plasma vitamin C in Alzheimer patients despite an adequate diet.
Int J Geriatr Psychiatry. 1998 Nov;13(11):749-54.
PMID: 9850871 [PubMed - indexed for MEDLINE]


6: Khalsa DS.Integrated medicine and the prevention and reversal of memory loss.
Altern Ther Health Med. 1998 Nov;4(6):38-43. Review.
PMID: 9810066 [PubMed - indexed for MEDLINE]

1: Pedersen WA, Wan R, Mattson MP.Impact of aging on stress-responsive neuroendocrine systems.
Mech Ageing Dev. 2001 Jul 15;122(9):963-83. Review.
PMID: 11348661 [PubMed - indexed for MEDLINE]


2: Knittweis J.Weight loss in cancer and Alzheimer's disease is mediated by a similar pathway.
Med Hypotheses. 1999 Aug;53(2):172-4. Review.
PMID: 10532714 [PubMed - indexed for MEDLINE]


3: Bunout D, Cambiazo V.[Nutrition and aging]
Rev Med Chil. 1999 Jan;127(1):82-8. Review. Spanish.
PMID: 10436685 [PubMed - indexed for MEDLINE]


4: Guyonnet S, Nourhashemi F, Ousset PJ, de Glisezinski I, Riviere D, AlbaredeJL, Vellas B.
[Alzheimer's disease and nutrition]
Rev Neurol (Paris). 1999 May;155(5):343-9. Review. French.
PMID: 10427597 [PubMed - indexed for MEDLINE]


5: Smith G, Vigen V, Evans J, Fleming K, Bohac D.Patterns and associates of hyperphagia in patients with dementia.
Neuropsychiatry Neuropsychol Behav Neurol. 1998 Apr;11(2):97-102.
PMID: 9652490 [PubMed - indexed for MEDLINE]


6: Drachman DA.Aging and the brain: a new frontier.
Ann Neurol. 1997 Dec;42(6):819-28. Review.
PMID: 9403473 [PubMed - indexed for MEDLINE]


7: Gabbita SP, Butterfield DA, Hensley K, Shaw W, Carney JM.Aging and caloric restriction affect mitochondrial respiration and lipid
membrane status: an electron paramagnetic resonance investigation.
Free Radic Biol Med. 1997;23(2):191-201.
PMID: 9199881 [PubMed - indexed for MEDLINE]

1: Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K.Physical activity and risk of cognitive impairment and dementia in elderly
persons.
Arch Neurol. 2001 Mar;58(3):498-504.
PMID: 11255456 [PubMed - indexed for MEDLINE]


2: Phaneuf S, Leeuwenburgh C.Apoptosis and exercise.
Med Sci Sports Exerc. 2001 Mar;33(3):393-6. Review.
PMID: 11252065 [PubMed - indexed for MEDLINE]


3: Mattson MP.Neuroprotective signaling and the aging brain: take away my food and let me run.
Brain Res. 2000 Dec 15;886(1-2):47-53. Review.
PMID: 11119686 [PubMed - indexed for MEDLINE]


4: Rolland Y, Rival L, Pillard F, Lafont C, Rivere D, Albarede J, Vellas B.Feasibily of regular physical exercise for patients with moderate to severe
Alzheimer disease.
J Nutr Health Aging. 2000;4(2):109-13.
PMID: 10842423 [PubMed - indexed for MEDLINE]


5: Arkin SM.Elder rehab: a student-supervised exercise program for Alzheimer's patients.
Gerontologist. 1999 Dec;39(6):729-35.
PMID: 10650683 [PubMed - indexed for MEDLINE]


6: Brinton RD.A women's health issue: Alzheimer's disease and strategies for maintaining
cognitive health.
Int J Fertil Womens Med. 1999 Jun-Aug;44(4):174-85. Review.
PMID: 10499738 [PubMed - indexed for MEDLINE]


7: Teri L, McCurry SM, Buchner DM, Logsdon RG, LaCroix AZ, Kukull WA, Barlow WE,Larson EB.
Exercise and activity level in Alzheimer's disease: a potential treatment focus.
J Rehabil Res Dev. 1998 Oct;35(4):411-9.
PMID: 10220219 [PubMed - indexed for MEDLINE]


8: Khalsa DS.Integrated medicine and the prevention and reversal of memory loss.
Altern Ther Health Med. 1998 Nov;4(6):38-43. Review.
PMID: 9810066 [PubMed - indexed for MEDLINE]


9: Broe GA, Creasey H, Jorm AF, Bennett HP, Casey B, Waite LM, Grayson DA,Cullen J.
Health habits and risk of cognitive impairment and dementia in old age: a
prospective study on the effects of exercise, smoking and alcohol consumption.
Aust N Z J Public Health. 1998 Aug;22(5):621-3.

PMID: 9744220 [PubMed - indexed for MEDLINE]

10: Shimamura K, Takatsuka N, Inaba R, Iwata H, Yoshida H.[Environmental factors possibly associated with onset of senile dementia]
Nippon Koshu Eisei Zasshi. 1998 Mar;45(3):203-12. Japanese.
PMID: 9623247 [PubMed - indexed for MEDLINE]


11: Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Joachim C,Litchfield S, Barnetson L, Smith AD.
The effects of additional pathology on the cognitive deficit in Alzheimer
disease.
J Neuropathol Exp Neurol. 1997 Feb;56(2):165-70.
PMID: 9034370 [PubMed - indexed for MEDLINE]


12: Crawford JG.Alzheimer's disease risk factors as related to cerebral blood flow.
Med Hypotheses. 1996 Apr;46(4):367-77. Review.
PMID: 8733167 [PubMed - indexed for MEDLINE]

1: Ingram DK.Vaccine development for Alzheimer's disease: a shot of good news.
Trends Neurosci. 2001 Jun;24(6):305-7.
PMID: 11356488 [PubMed - indexed for MEDLINE]


2: Emre M, Qizilbash N.Experimental approaches and drugs in development for the treatment of dementia.
Expert Opin Investig Drugs. 2001 Apr;10(4):607-17. Review.
PMID: 11281812 [PubMed - indexed for MEDLINE]


3: Effros RB.Ageing and the immune system.
Novartis Found Symp. 2001;235:130-9; discussion 139-45, 146-9. Review.
PMID: 11280023 [PubMed - indexed for MEDLINE]


4: Frenkel D, Kariv N, Solomon B.Generation of auto-antibodies towards Alzheimer's disease vaccination.
Vaccine. 2001 Mar 21;19(17-19):2615-9.
PMID: 11257400 [PubMed - indexed for MEDLINE]


5: Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K,Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash
GW.
A beta peptide vaccination prevents memory loss in an animal model of
Alzheimer's disease.
Nature. 2000 Dec 21-28;408(6815):982-5.
PMID: 11140686 [PubMed - indexed for MEDLINE]

1   2   3   4   5   6   7   8   9

similar:

¿Qué es la enfermedad de Alzheimer? icon¿QUÉ tal que ya existiera la cura para la enfermedad de alzheimer y nadie lo supiera?

¿Qué es la enfermedad de Alzheimer? iconEnfermedad de Alzheimer

¿Qué es la enfermedad de Alzheimer? iconEnfermedad de Alzheimer De Wikipedia, la enciclopedia libre

¿Qué es la enfermedad de Alzheimer? iconConclusiones "Los costes de la enfermedad de Alzheimer"

¿Qué es la enfermedad de Alzheimer? iconSujeciones químicas en personas con enfermedad de Alzheimer

¿Qué es la enfermedad de Alzheimer? iconEfectos del ejercicio multimodal en pacientes con la enfermedad de...

¿Qué es la enfermedad de Alzheimer? icon¿Qué es una enfermedad transmitida por alimentos?

¿Qué es la enfermedad de Alzheimer? icon1. Explica en qué consiste la progeria e indica los problemas de...

¿Qué es la enfermedad de Alzheimer? iconAula 1 Química. Campus Libertad. Av Libertad 5470. Corrientes
«sin carga», entendiéndose por carga un impuesto, ley o enfermedad. Se dice que aquellos individuos que no sucumben ante la enfermedad...

¿Qué es la enfermedad de Alzheimer? icon¿Qué provoca el enfrentamiento de Sempronio y Celestina?(pp. 120-121)...
«pecado» para Celestina? ¿Qué remedio infalible le sugiere a Areúsa para curar su mal? (p. 154) ¿Qué última lección le da Celestina...


Medicina



Todos los derechos reservados. Copyright © 2015
contactos
med.se-todo.com